Qin Y - Search Results

1

Characterization of precipitation from citrus vinegar during ageing: chemical constituents, formation mechanism and anti-proliferative effect.

Hu F, Qin Y, Zhou Y, Li L, Wang Y, Deng Z. Hu F, et al. Among authors: qin y. Food Funct. 2022 May 10;13(9):4930-4940. doi: 10.1039/d2fo00513a. Food Funct. 2022. PMID: 35403181

2

KDM1A Identified as a Potential Oncogenic Driver and Prognostic Biomarker via Multi-Omics Analysis.

Li L, Wang Y, Mou Y, Wu H, Qin Y. Li L, et al. Among authors: qin y. Can J Infect Dis Med Microbiol. 2021 Dec 9;2021:4668565. doi: 10.1155/2021/4668565. eCollection 2021. Can J Infect Dis Med Microbiol. 2021. PMID: 34925656 Free PMC article.

3

Naphthoquinones from Catalpa bungei "Jinsi" as potent antiproliferation agents inducing DNA damage.

Qin Y, Liu S, Zou Q, Cai X, Guo Z, Yu L, Wang J, Deng Z. Qin Y, et al. Fitoterapia. 2022 Jul;160:105196. doi: 10.1016/j.fitote.2022.105196. Epub 2022 Apr 12. Fitoterapia. 2022. PMID: 35427755

4

Dehydrocurvularin-loaded mPEG-PLGA nanoparticles for targeted breast cancer drug delivery: preparation, characterization, in vitro, and in vivo evaluation.

Cui X, He Z, Liang J, Wei M, Guo Z, Zhou Y, Qin Y, Deng Z. Cui X, et al. Among authors: qin y. J Drug Target. 2024 Dec;32(3):325-333. doi: 10.1080/1061186X.2024.2309566. Epub 2024 Feb 1. J Drug Target. 2024. PMID: 38269592

5

Citrus polymethoxyflavones degrade estrogen receptor-alpha (ERα) and combine with tamoxifen for the treatment of estrogen receptor-positive breast cancer.

Wang Y, Sun M, He Z, Han Y, Song Y, Liang J, Wang H, Qin Y, Deng Z. Wang Y, et al. Among authors: qin y. Heliyon. 2024 Jun 14;10(12):e33104. doi: 10.1016/j.heliyon.2024.e33104. eCollection 2024 Jun 30. Heliyon. 2024. PMID: 39022050 Free PMC article.

6

[Effects of a novel polyamine metabolic enzyme inhibitor SI-4650 on proliferation of colon cancer CT-26 cells and its mechanism].

Huang JJ, Wang YL, Sun LD, Cao CY, Qin Y, Yang JL. Huang JJ, et al. Among authors: qin y. Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2020 Jul;36(4):330-335. doi: 10.12047/j.cjap.5968.2020.071. Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2020. PMID: 33167093 Free article. Chinese.

7

Targeting LSD1 in tumor immunotherapy: rationale, challenges and potential.

Bao L, Zhu P, Mou Y, Song Y, Qin Y. Bao L, et al. Among authors: qin y. Front Immunol. 2023 Jul 7;14:1214675. doi: 10.3389/fimmu.2023.1214675. eCollection 2023. Front Immunol. 2023. PMID: 37483603 Free PMC article. Review.

8

Apoptotic Melanoma B16-F1 Cells Induced by Lidamycin Could Initiate the Antitumor Immune Response in BABL/c Mice.

Yang JL, Qin Y, Li L, Cao CY, Wang Q, Li Q, Lv YF, Wang Y. Yang JL, et al. Among authors: qin y. Oncol Res. 2016 Jan 21;23(1-2):79-86. doi: 10.3727/096504015X14478843952942. Oncol Res. 2016. PMID: 26802654 Free PMC article.

9

An engineered PD-1-based and MMP-2/9-oriented fusion protein exerts potent antitumor effects against melanoma.

Wei M, Liu X, Cao C, Yang J, Lv Y, Huang J, Wang Y, Qin Y. Wei M, et al. Among authors: qin y. BMB Rep. 2018 Nov;51(11):572-577. doi: 10.5483/BMBRep.2018.51.11.076. BMB Rep. 2018. PMID: 30021673 Free PMC article.

10

Functional characterization of lysine-specific demethylase 2 (LSD2/KDM1B) in breast cancer progression.

Chen L, Vasilatos SN, Qin Y, Katz TA, Cao C, Wu H, Tasdemir N, Levine KM, Oesterreich S, Davidson NE, Huang Y. Chen L, et al. Among authors: qin y. Oncotarget. 2017 Jul 19;8(47):81737-81753. doi: 10.18632/oncotarget.19387. eCollection 2017 Oct 10. Oncotarget. 2017. PMID: 29137219 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,941 results

Search Page

Filters